GO:0098907 regulation of SA node cell action potential: Pacemaker Physiology, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0098907 describes any process that modulates the frequency, rate or extent of action potential creation, propagation or termination in a sinoatrial (SA) node cardiac myocyte, typically via voltage-gated ion channels.
• The SA node action potential is driven by the interplay of a membrane clock (HCN4, Cav1.3, Cav3.1, Nav1.5, Kv channels) and a calcium clock (RyR2, SERCA2a, NCX1).
• HCN4 is the principal pacemaker channel; its hysteresis and cAMP sensitivity are central to autonomic chronotropic control.
• Adenosine, GLP-1 and AMPK signalling are established modulators of SA node firing rate, demonstrating the term's physiological breadth.
• Dysregulation of SA node action potential regulation underlies sinus node dysfunction, bradyarrhythmias and inappropriate sinus tachycardia.
• CRISPR knockout, point-mutation, knock-in and overexpression models in hiPSC-derived SA node-like cells enable causal dissection of GO:0098907.
Description
The sinoatrial (SA) node is the primary pacemaker of the mammalian heart, and its spontaneous action potentials set the rhythm of the entire organ. GO:0098907, regulation of SA node cell action potential, captures the biological processes that modulate the frequency, rate or extent of action potential creation, propagation or termination in SA node cardiac myocytes, typically through changes in the activity or expression of voltage-gated ion channels. Because the SA node action potential is generated by a coupled membrane clock and calcium clock, its regulation is inherently multi-ionic and multi-protein. Understanding this term is therefore essential for researchers studying cardiac automaticity, chronotropic pharmacology and sinus node disease. Mechanistically, the SA node action potential is not a single event but a cycle of diastolic depolarization, threshold crossing, upstroke, and repolarization, each phase shaped by distinct conductances. The hyperpolarization-activated cyclic nucleotide-gated channel HCN4 carries the funny current (If) that initiates diastolic depolarization, while T-type and L-type calcium channels (Cav3.1, Cav1.3) contribute to the later phase and upstroke. Ryanodine receptor 2 (RyR2)-mediated sarcoplasmic reticulum calcium release and sodium-calcium exchanger 1 (NCX1) provide the calcium clock that reinforces the membrane clock. Autonomic and metabolic inputs, including adenosine, glucagon-like peptide-1 (GLP-1) and AMPK signalling, tune these conductances to adjust heart rate. For biomedical researchers, GO:0098907 provides a structured framework to annotate genes, interpret transcriptomic and electrophysiological data, and design perturbation experiments. It is directly relevant to sinus node dysfunction, bradyarrhythmias, and drug-induced chronotropic effects, and it is increasingly studied in human induced pluripotent stem cell (hiPSC)-derived SA node-like cells. This article integrates the QuickGO definition with verified PubMed literature to describe the mechanisms, key genes, disease links, and CRISPR-based research methods associated with GO:0098907.
regulation of SA node cell action potential At A Glance
| GO ID | GO:0098907 |
|---|---|
| GO term | regulation of SA node cell action potential |
| Ontology | biological_process |
| Synonym | regulation of SAN cardiac muscle cell action potential; regulation of SA node cardiac muscle cell action potential; regulation of sinoatrial node cardiac muscle cell action potential; regulation of sinus node cardiac muscle cell action potential |
| Major function | Modulates the frequency, rate or extent of action potential creation, propagation or termination in SA node cardiac myocytes, typically via voltage-gated ion channels |
| Cellular location | Sinoatrial node cardiac myocyte plasma membrane and sarcoplasmic reticulum |
| Key currents | If (HCN4), ICaT (Cav3.1), ICaL (Cav1.3), INa (Nav1.5), IK (Kv channels), INCX (NCX1) |
| Principal modulators | Autonomic cAMP signalling, adenosine, GLP-1, AMPK |
| Disease relevance | Sinus node dysfunction, bradyarrhythmias, inappropriate sinus tachycardia |
What Is GO:0098907?
GO:0098907, regulation of SA node cell action potential, is a biological process defined as any process that modulates the frequency, rate or extent of action potential creation, propagation or termination in an SA node cardiac myocyte. This regulation typically occurs via modulation of the activity or expression of voltage-gated ion channels. In other words, it covers all molecular and cellular events that change how often, how fast, or how completely SA node cells fire action potentials, with ion channel modulation as the principal effector mechanism.
Why Is regulation of SA node cell action potential Important in Cell Biology?
GO:0098907 is important because the SA node action potential is the origin of every heartbeat, and its regulation determines heart rate under rest, exercise, and disease. Perturbations in the ion channels and signalling pathways that regulate SA node firing cause clinically significant arrhythmias, including sinus node dysfunction and bradyarrhythmias. Moreover, many drugs and metabolic states alter heart rate by acting on these same regulatory processes, making GO:0098907 a central term for cardiac pharmacology, toxicology, and regenerative medicine.
• Defines the molecular basis of cardiac automaticity and heart rate control.
• Provides an annotation framework for genes encoding SA node ion channels and calcium-handling proteins.
• Links to sinus node dysfunction and bradyarrhythmias in human disease.
• Explains drug-induced chronotropic effects, including GLP-1 and adenosine responses.
• Supports hiPSC-based disease modelling and SA node-like cell differentiation.
• Guides CRISPR perturbation studies of HCN4, Cav1.3, RyR2 and related genes.
• Informs bioinformatics analysis of cardiac conduction system transcriptomes.
• Connects membrane clock and calcium clock mechanisms in a single ontology term.
• Enables cross-species comparison of pacemaker physiology.
• Underpins development of rate-modulating therapeutics and biological pacemakers.
What Happens During regulation of SA node cell action potential?
Diastolic depolarization and the funny current (If)
In simple terms: The SA node cell slowly drifts upward in voltage until it reaches threshold, and HCN4 channels carry the current that starts this drift.
Diastolic depolarization is the spontaneous, slow rise in membrane potential that initiates each SA node action potential. The hyperpolarization-activated cyclic nucleotide-gated channel HCN4 conducts the funny current (If), which is activated by hyperpolarization and modulated by cAMP, and is a principal determinant of the slope of diastolic depolarization. HCN4 channel hysteresis, a feature in which the voltage dependence of activation differs between depolarizing and hyperpolarizing ramps, is proposed to be crucial for stable sinoatrial node pacemaking. Regulation of If by autonomic signalling therefore directly modulates the frequency of SA node action potential creation, placing HCN4 at the core of GO:0098907.
Calcium clock and sarcoplasmic reticulum calcium release
In simple terms: Inside the cell, calcium released from internal stores helps push the membrane voltage toward threshold, reinforcing the pacemaker signal.
The calcium clock involves spontaneous, rhythmic release of calcium from the sarcoplasmic reticulum through ryanodine receptor 2 (RyR2), followed by calcium extrusion via sodium-calcium exchanger 1 (NCX1), which generates an inward current that contributes to diastolic depolarization. This local calcium release is coupled to the membrane clock through NCX1 and calcium-sensitive signalling, and uncoupling of the two clocks reduces SA node cell action potential firing rate. Calcium signalling in cardiomyocytes is thus an integral component of GO:0098907, and its regulation by SERCA2a, phospholamban, and calmodulin-dependent kinases shapes pacemaker frequency.
Upstroke and repolarization: voltage-gated calcium and potassium channels
In simple terms: Once threshold is reached, calcium channels drive the upstroke, and potassium channels bring the cell back down.
The SA node action potential upstroke is primarily mediated by L-type calcium current (ICaL) through Cav1.3 channels, with contributions from T-type calcium current (ICaT) through Cav3.1 channels, while Nav1.5 contributes in some species and regions. Repolarization is driven by potassium currents, including rapidly and slowly activating delayed rectifier currents, and by inactivation of calcium channels. Modulation of the expression or activity of these voltage-gated ion channels changes action potential duration and firing rate, which is the defining mechanism of GO:0098907.
Autonomic and metabolic modulation of SA node firing
In simple terms: Hormones and metabolic signals speed up or slow down the pacemaker by changing ion channel behaviour.
Autonomic inputs regulate SA node action potential frequency through cAMP-dependent modulation of HCN4 and calcium channels, and through phosphorylation of calcium-handling proteins. Adenosine reduces SA node cell action potential firing rate by uncoupling the membrane and calcium clocks, providing a direct example of regulation within GO:0098907. Glucagon-like peptide-1 (GLP-1) increases heart rate by a direct action on the sinus node, demonstrating hormonal modulation of the term. In addition, AMPK signalling influences differentiation and function of SA node-like cells, linking metabolic state to pacemaker regulation.
Transcriptional control of SA node identity and channel expression
In simple terms: Which ion channels a pacemaker cell makes is controlled by transcription factors, so gene regulation shapes the action potential.
Transcriptional regulation of the cardiac conduction system determines the expression profile of ion channels and calcium-handling proteins that underlie SA node action potentials. Transcription factors and regulatory networks that specify the SA node lineage establish the molecular composition required for spontaneous activity, and their perturbation can alter action potential regulation. This transcriptional layer is part of GO:0098907 because changes in ion channel expression directly modulate action potential creation and propagation.
Key Genes Involved in GO:0098907 regulation of SA node cell action potential
The following genes encode the principal ion channels, calcium-handling proteins, and signalling molecules that regulate SA node cell action potentials.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HCN4 | Pacemaker channel carrying If; cAMP-modulated | Core regulator of diastolic depolarization and heart rate |
| CACNA1D | L-type calcium channel Cav1.3 mediating ICaL | Upstroke and action potential duration in SA node |
| CACNA1G | T-type calcium channel Cav3.1 mediating ICaT | Late diastolic depolarization and pacemaker stability |
| SCN5A | Voltage-gated sodium channel Nav1.5 | Contributes to SA node action potential in some regions/species |
| RYR2 | Ryanodine receptor 2; SR calcium release | Calcium clock component modulating firing rate |
| ATP2A2 | SERCA2a calcium pump; SR calcium reuptake | Shapes calcium clock and pacemaker frequency |
| SLC8A1 | Sodium-calcium exchanger NCX1 | Couples calcium clock to membrane depolarization |
| KCNQ1 | Potassium channel contributing to repolarization | Modulates action potential duration in pacemaker cells |
| KCNH2 | hERG potassium channel; IKr | Repolarization reserve and arrhythmia risk |
| ADORA1 | Adenosine A1 receptor | Adenosine-mediated slowing of SA node firing |
| GLP1R | GLP-1 receptor | Direct hormonal modulation of sinus node rate |
| PRKAA1 | AMPK catalytic subunit alpha 1 | Metabolic regulation of SA node-like cell differentiation |
| PRKAA2 | AMPK catalytic subunit alpha 2 | AMPK signalling in pacemaker cell function |
| CALM1 | Calmodulin; calcium sensor | Regulates calcium-dependent ion channel activity |
| CAMK2D | CaMKII delta; calcium-dependent kinase | Modulates calcium handling and pacemaker frequency |
| PLN | Phospholamban; SERCA2a inhibitor | Regulates SR calcium load and calcium clock |
| TBX3 | Transcription factor in conduction system | Controls SA node gene expression programs |
| SHOX2 | Transcription factor in pacemaker cells | Regulates SA node identity and channel expression |
How Is regulation of SA node cell action potential Regulated?
Regulation of SA node cell action potential is itself regulated at multiple levels. Autonomic cAMP signalling modulates HCN4 and calcium channels, altering the slope of diastolic depolarization and heart rate. Adenosine reduces firing rate by uncoupling the membrane and calcium clocks, while GLP-1 increases heart rate via a direct sinus node action. Metabolic signalling through AMPK influences SA node-like cell differentiation and function. Transcriptional networks controlling cardiac conduction system identity determine the expression of ion channels and calcium-handling proteins, providing a longer-term regulatory layer.
regulation of SA node cell action potential and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HCN4 | Sinus node dysfunction, bradycardia | HCN4 knockout or point-mutation hiPSC-derived SA node-like cells |
| RYR2 | Calcium clock dysfunction, arrhythmia | RYR2 knock-in or knockout cardiomyocytes |
| SLC8A1 | Impaired calcium clock coupling | NCX1 knockout or overexpression models |
| ADORA1 | Adenosine-mediated bradycardia | ADORA1 knockout or overexpression in pacemaker cells |
| GLP1R | Hormonal heart rate regulation | GLP1R knockout or knock-in models |
Sinus node dysfunction and bradyarrhythmias
Impaired regulation of SA node cell action potentials can cause sinus node dysfunction, characterized by inappropriate bradycardia, sinus pauses, and chronotropic incompetence. Dysfunction of HCN4 and other pacemaker channels is linked to inherited and acquired bradyarrhythmias, and altered autonomic modulation contributes to disease phenotypes. Because GO:0098907 encompasses the modulation of ion channel activity and expression, it provides a mechanistic framework for understanding these disorders.
Drug-induced and hormonal chronotropic effects
Many pharmacological agents change heart rate by acting on pathways that regulate SA node action potentials. Adenosine reduces SA node cell action potential firing rate by uncoupling the membrane and calcium clocks, and GLP-1 increases heart rate by a direct action on the sinus node. These examples illustrate how GO:0098907 is relevant to drug safety, endocrine-cardiac interactions, and therapeutic heart rate control.
Arrhythmia risk and channelopathies
Variants in genes encoding SA node ion channels and calcium-handling proteins can alter action potential regulation and predispose to arrhythmias. HCN4 channel dysfunction and altered calcium clock components have been implicated in pacemaker-related disease, and repolarization abnormalities involving potassium channels can increase arrhythmia susceptibility. Studying GO:0098907 helps connect molecular channel defects to clinical phenotypes.
From regulation of SA node cell action potential-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of HCN4 abolish SA node automaticity? | HCN4 knockout hiPSC-derived SA node-like cells |
| Does a specific HCN4 point mutation alter channel hysteresis? | HCN4 point-mutation knock-in cell model |
| Does AMPK signalling regulate SA node-like differentiation? | AMPK subunit knockout or overexpression |
| Does adenosine uncouple membrane and calcium clocks? | ADORA1 knockout or overexpression in pacemaker cells |
| Does GLP-1 directly modulate sinus node firing? | GLP1R knockout or tagged knock-in |
| Can transcriptional regulators reprogram pacemaker gene expression? | TBX3 or SHOX2 knockout/overexpression |
How to Study the regulation of SA node cell action potential Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Action potential firing rate and ionic currents | Functional validation of pacemaker genes |
| Calcium imaging | SR calcium release and calcium transients | Calcium clock assessment |
| RNA sequencing | Transcript levels of ion channels and regulators | Gene expression profiling in SA node models |
| Bioinformatics pathway analysis | Enrichment of GO terms and pathways | Annotation and candidate prioritization |
| hiPSC differentiation | Generation of SA node-like cells | Disease modelling and drug testing |
| CRISPR perturbation | Causal gene function | Knockout, knock-in, point mutation studies |
| Pharmacological profiling | Chronotropic drug responses | Testing adenosine, GLP-1, and other modulators |
| Transcriptional reporter assays | Promoter and enhancer activity | Studying conduction system gene regulation |
Patch-clamp electrophysiology
Patch-clamp recording measures action potentials and ionic currents directly in SA node cells, allowing quantification of firing rate, diastolic depolarization slope, and the contributions of If, ICaL, ICaT, and potassium currents. This method is essential for functional validation of genes annotated to GO:0098907.
Calcium imaging
Calcium imaging with fluorescent indicators detects spontaneous sarcoplasmic reticulum calcium release and calcium transients, providing readouts of the calcium clock. It is used to test whether perturbations uncouple the membrane and calcium clocks, as shown for adenosine.
Transcriptomics and bioinformatics
RNA sequencing and bioinformatic analysis of SA node and conduction system tissues or hiPSC-derived cells identify expression signatures of ion channels and regulatory transcription factors. These approaches help annotate genes to GO:0098907 and prioritize candidates for perturbation.
hiPSC-derived SA node-like cell models
Human induced pluripotent stem cells can be differentiated into SA node-like cells that exhibit spontaneous action potentials, enabling disease modelling and drug testing. Programmed regulation of AMPK signalling has been used to promote this differentiation, providing a platform for studying GO:0098907.
How CRISPR Can Be Used to Study GO:0098907 regulation of SA node cell action potential
Knockout
CRISPR knockout of genes such as HCN4, RYR2, or ADORA1 in hiPSC-derived SA node-like cells can test whether the gene is required for spontaneous action potentials and normal firing rate. Loss-of-function models help establish causal roles within GO:0098907.
Point Mutation
Point-mutation knock-in can recreate disease-associated variants in ion channel genes, such as HCN4 variants affecting channel hysteresis, to dissect how specific residues alter action potential regulation. These models are valuable for linking genotype to pacemaker dysfunction.
Knock-in
Knock-in of reporter tags or fluorescent markers into endogenous loci, such as HCN4 or GLP1R, enables live tracking of channel expression and localization in SA node cells. Tagged knock-in models support imaging and biochemical studies of GO:0098907 components.
Overexpression
Overexpression of pacemaker genes or signalling regulators, such as AMPK subunits or GLP1R, can enhance or suppress SA node action potential firing. Overexpression models are useful for gain-of-function studies and for engineering biological pacemakers.
How EDITGENE Supports regulation of SA node cell action potential Research
Researchers studying regulation of SA node cell action potential-related genes often need to determine whether a candidate gene is causally involved in pacemaker function, and CRISPR-based cell models provide a direct route to that answer. EDITGENE offers a suite of services tailored to this need, from knockout to overexpression and library screening.
Contact EDITGENE today to design your custom CRISPR model for regulation of SA node cell action potential research.
Frequently Asked Questions About regulation of SA node cell action potential
What is GO:0098907?
GO:0098907 is the Gene Ontology term for regulation of SA node cell action potential, defined as any process that modulates the frequency, rate or extent of action potential creation, propagation or termination in an SA node cardiac myocyte, typically via voltage-gated ion channels.
What genes are involved in regulation of SA node cell action potential?
Key genes include HCN4, CACNA1D, CACNA1G, SCN5A, RYR2, ATP2A2, SLC8A1, KCNQ1, KCNH2, ADORA1, GLP1R, and AMPK subunits, among others.
How does the funny current regulate SA node firing?
The funny current (If), carried by HCN4, is activated by hyperpolarization and modulated by cAMP, and it initiates diastolic depolarization, thereby controlling the frequency of SA node action potentials.
What is the calcium clock in the SA node?
The calcium clock is the rhythmic release of calcium from the sarcoplasmic reticulum via RyR2 and its extrusion by NCX1, which generates an inward current that reinforces diastolic depolarization.
How does adenosine affect SA node action potentials?
Adenosine reduces SA node cell action potential firing rate by uncoupling the membrane and calcium clocks.
Does GLP-1 affect heart rate through the sinus node?
Yes, GLP-1 increases heart rate by a direct action on the sinus node.
What diseases are linked to dysregulated SA node action potentials?
Sinus node dysfunction, bradyarrhythmias, and arrhythmia risk are linked to dysregulation of SA node action potential regulation.
How can I study GO:0098907 in the lab?
Patch-clamp electrophysiology, calcium imaging, transcriptomics, and hiPSC-derived SA node-like cell models are commonly used to study this process.
Can CRISPR be used to study SA node pacemaker genes?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of pacemaker genes such as HCN4 and RYR2.
What is the role of AMPK in SA node-like cells?
AMPK signalling promotes differentiation of human induced pluripotent stem cells into SA node-like cells, linking metabolic regulation to pacemaker function.
Conclusion
GO:0098907, regulation of SA node cell action potential, is a central biological process that integrates membrane clock and calcium clock mechanisms to control heart rate. Its molecular players, including HCN4, Cav1.3, Cav3.1, RyR2, NCX1, and autonomic signalling pathways, are well-documented in the literature and are directly relevant to sinus node dysfunction and chronotropic pharmacology. CRISPR-based cell models, combined with electrophysiology, calcium imaging, and bioinformatics, provide powerful tools to dissect this process and identify new therapeutic targets. Researchers can leverage these approaches to advance understanding of SA node biology and related diseases.
References
- 1. Gilbert G et al.. 2020. Calcium Signaling in Cardiomyocyte Function.. Cold Spring Harb Perspect Biol 12(3) PMID: 31308143
- 2. Hennis K et al.. 2024. Pacemaker Channels and the Chronotropic Response in Health and Disease.. Circ Res 134(10):1348-1378 PMID: 38723033
- 3. Lubberding AF et al.. 2024. Glucagon-like peptide-1 increases heart rate by a direct action on the sinus node.. Cardiovasc Res 120(12):1427-1441 PMID: 38832935
- 4. Wirth AN et al.. 2022. Adenosine reduces sinoatrial node cell action potential firing rate by uncoupling its membrane and calcium clocks.. Front Physiol 13:977807 PMID: 36505046
- 5. Xiao YF et al.. 2010. Hysteresis in human HCN4 channels: a crucial feature potentially affecting sinoatrial node pacemaking.. Sheng Li Xue Bao 62(1):1-13 PMID: 20179882
- 6. van Eif VWW et al.. 2018. Transcriptional regulation of the cardiac conduction system.. Nat Rev Cardiol 15(10):617-630 PMID: 29875439
- 7. Herrmann S et al.. 2007. Pathophysiology of HCN channels.. Pflugers Arch 454(4):517-22 PMID: 17549513
- 8. Liu F et al.. 2025. Promoting differentiation of human-induced pluripotent stem cells into sinoatrial node-like cells through programmed regulation of AMPK signalling pathway.. Europace 27(11) PMID: 41206581
